In this Email

• Funding Opportunities
• Learn from the Experts: Upcoming Webinars

Funding Opportunities

Next Omnibus Solicitation Receipt Date is January 5

SBIR Phase I, Phase II, and Fast-Track PA-15-269

STTR Phase I, Phase II, and Fast-Track PA-15-270

SBIR Direct-to-Phase II PAR-14-088

NHLBI Small Business Topics of Special Interest

Funding Deadlines

January 5  - New Technologies for Viral Hepatitis (SBIR PA-15-077, STTR PA-15-076)

January 5 - Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR PA-13-140)

January 5  - Safe and Effective Instruments and Devices for Use in Neonatal and Pediatric Care Settings (SBIR PAR-13-090, STTR PAR-13-091)

February 20 - Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement (SBIR RFA-HL-15-030)

Register for the webinar on December 16: http://bit.ly/BloodProductsWebinar

Contact us at nhlbi_sbir@mail.nih.gov to talk about which funding opportunity is the right fit for your technology.

Learn from the Experts: Upcoming Webinars

December 16 – NHLBI Funding Opportunity: Stem Cell-Derived Blood Products for Therapeutic Use: Technology Improvement

January 12 – Next Small Biz Hangout: Reimbursement Basics

The NHLBI SBIR/STTR Programs provide support for small businesses developing and commercializing novel technologies and products to promote the prevention, diagnosis, and treatment of heart, lung, blood, and sleep diseases and disorders. The NHLBI provides grant and contract funding for research and development of technologies related to the mission of NHLBI. For more information about the NHLBI SBIR/STTR Program, including funding opportunities, visit our web page.

@NHLBI_SBIR  |  Sign up or adjust your subscription at the NHLBI-SBIR subscriber page